Goldman Sachs’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.2M Buy
851,464
+64,195
+8% +$1.34M ﹤0.01% 2521
2025
Q4
$16.8M Buy
787,269
+20,714
+3% +$424K ﹤0.01% 2550
2025
Q3
$12.8M Sell
766,555
-23,988
-3% -$360K ﹤0.01% 2722
2025
Q2
$11.3M Buy
790,543
+224,789
+40% +$3.08M ﹤0.01% 2648
2025
Q1
$8.2M Sell
565,754
-102,013
-15% -$1.45M ﹤0.01% 2879
2024
Q4
$8.76M Sell
667,767
-183,679
-22% -$2.54M ﹤0.01% 2925
2024
Q3
$9.87M Buy
851,446
+258,393
+44% +$2.44M ﹤0.01% 2745
2024
Q2
$4.48M Buy
593,053
+387,844
+189% +$3.21M ﹤0.01% 3249
2024
Q1
$2.06M Sell
205,209
-87,294
-30% -$812K ﹤0.01% 3847
2023
Q4
$2.72M Sell
292,503
-420,088
-59% -$4.35M ﹤0.01% 3679
2023
Q3
$9.06M Sell
712,591
-36,415
-5% -$500K ﹤0.01% 2475
2023
Q2
$10.6M Buy
749,006
+362,052
+94% +$5.08M ﹤0.01% 2389
2023
Q1
$5.77M Buy
386,954
+6,534
+2% +$99K ﹤0.01% 2920
2022
Q4
$5.65M Buy
380,420
+148,612
+64% +$2.42M ﹤0.01% 3059
2022
Q3
$3.83M Sell
231,808
-1,777
-0.8% -$35.8K ﹤0.01% 3376
2022
Q2
$4.91M Buy
233,585
+37,941
+19% +$774K ﹤0.01% 3150
2022
Q1
$4.59M Sell
195,644
-14,868
-7% -$364K ﹤0.01% 3434
2021
Q4
$5.73M Sell
210,512
-32,675
-13% -$875K ﹤0.01% 3276
2021
Q3
$6.91M Sell
243,187
-3,462
-1% -$105K ﹤0.01% 3073
2021
Q2
$7.44M Sell
246,649
-36,951
-13% -$1.09M ﹤0.01% 2986
2021
Q1
$7.22M Buy
283,600
+25,985
+10% +$666K ﹤0.01% 2824
2020
Q4
$6.32M Sell
257,615
-159,904
-38% -$3M ﹤0.01% 2838
2020
Q3
$6.8M Buy
417,519
+18,739
+5% +$349K ﹤0.01% 2657
2020
Q2
$6.82M Sell
398,780
-40,696
-9% -$603K ﹤0.01% 2560
2020
Q1
$5.12M Sell
439,476
-267,679
-38% -$5.52M ﹤0.01% 2618
2019
Q4
$19.7M Sell
707,155
-88,204
-11% -$2.21M 0.01% 1887
2019
Q3
$18M Sell
795,359
-106,774
-12% -$2.43M 0.01% 1869
2019
Q2
$22.8M Buy
902,133
+95,057
+12% +$2.55M 0.01% 1744
2019
Q1
$21.9M Buy
807,076
+454,536
+129% +$15.2M 0.01% 1791
2018
Q4
$11.6M Sell
352,540
-109,112
-24% -$4.39M ﹤0.01% 2237
2018
Q3
$21.5M Sell
461,652
-72,312
-14% -$3.32M 0.01% 1855
2018
Q2
$23.1M Buy
533,964
+80,216
+18% +$3.84M 0.01% 1768
2018
Q1
$25.2M Sell
453,748
-330,297
-42% -$18.1M 0.01% 1658
2017
Q4
$41.9M Buy
784,045
+149,558
+24% +$7.06M 0.01% 1418
2017
Q3
$27.4M Sell
634,487
-450,827
-42% -$21.4M 0.01% 1745
2017
Q2
$65.5M Sell
1,085,314
-51,432
-5% -$3.05M 0.02% 1067
2017
Q1
$78.9M Sell
1,136,746
-153,045
-12% -$10.6M 0.02% 917
2016
Q4
$86M Buy
1,289,791
+254,596
+25% +$16.6M 0.02% 885
2016
Q3
$68.6M Buy
1,035,195
+312,698
+43% +$21.4M 0.02% 975
2016
Q2
$52.3M Sell
722,497
-394,459
-35% -$27.1M 0.02% 1083
2016
Q1
$72.2M Buy
1,116,956
+66,098
+6% +$4.38M 0.02% 836
2015
Q4
$75.3M Buy
1,050,858
+301,339
+40% +$22.3M 0.02% 834
2015
Q3
$57.6M Sell
749,519
-8,871
-1% -$716K 0.02% 942
2015
Q2
$56.2M Sell
758,390
-91,825
-11% -$6.61M 0.02% 1033
2015
Q1
$61.6M Buy
850,215
+82,885
+11% +$5.76M 0.02% 942
2014
Q4
$50.7M Buy
767,330
+172,963
+29% +$10.6M 0.02% 1075
2014
Q3
$32.6M Sell
594,367
-111,988
-16% -$6.35M 0.01% 1418
2014
Q2
$41.1M Sell
706,355
-613,354
-46% -$36.1M 0.01% 1248
2014
Q1
$81.8M Buy
1,319,709
+8,570
+0.7% +$499K 0.03% 711
2013
Q4
$70M Buy
1,311,139
+77,931
+6% +$4.18M 0.02% 828
2013
Q3
$61.9M Buy
1,233,208
+83,396
+7% +$4.07M 0.02% 839
2013
Q2
$52.6M Buy
+1,149,812
New +$51.5M 0.02% 873

Other funds holding MD

Goldman Sachs's MD Position: Q1 2026 in Review

Goldman Sachs increased its Pediatrix Medical (MD) stake by 8.2% in Q1 2026, buying an estimated $1.34M and bringing the position to 851,464 shares worth $18.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2521.

Goldman Sachs first reported a position in MD in Q2 2013 and has held it in 52 quarters since. The position peaked at $86M in Q4 2016. 296 funds tracked by Wall St. Rank hold MD as of Q1 2026.

  • Goldman Sachs held 851,464 shares of Pediatrix Medical worth $18.2M as of Q1 2026.
  • Goldman Sachs bought 64,195 Pediatrix Medical shares in Q1 2026, an estimated $1.34M.
  • Pediatrix Medical made up ﹤0.01% of Goldman Sachs's portfolio in Q1 2026, its #2521 holding.
  • Goldman Sachs first reported a position in Pediatrix Medical in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Pediatrix Medical position peaked at $86M in Q4 2016.
  • 296 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.